Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Resolution . These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis of (R)-p-hydroxyphenylglycine via phenol condensation offers high yield and purity for beta-lactam antibiotic manufacturing, ensuring robust supply chain continuity.
Patent CN101659623A details a novel chemical resolution for leucine and isoleucine using DBTA, offering high purity and recyclable agents for reliable supply chains.
Patent CN105384608A details a novel route for isopropyl-phenol derivatives. This report analyzes cost reduction in API manufacturing and supply chain reliability for high-purity intermediates.
Discover the patented synthesis of (2S)-indoline-2-carboxylic acid. A reliable pharmaceutical intermediates supplier offering cost reduction in API manufacturing via novel resolution.
Patent CN107759466B details a water-based chiral resolution for S-(+)-Ketoprofen. Achieve high purity with reduced resolving agent costs and green manufacturing.
Discover a novel synthetic route for Tapentadol Hydrochloride offering mild conditions and high purity. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN107540601B details a cost-effective route for Avibactam intermediates using Pidolidone, offering significant supply chain and purity advantages for manufacturers.
Patent CN1163472C details a novel one-pot resolution of racemic hydantoin for high-purity chiral amino acids, offering significant cost and supply chain advantages.
Patent CN104232730A details enzymatic resolution for high-purity intermediates. Achieve significant cost reduction and supply chain reliability in pharmaceutical manufacturing.
Patent CN1442407A details a cost-effective resolution method for fexofenadine intermediates, ensuring high purity and scalable supply chain reliability for global pharmaceutical partners.
Patent CN115058406A reveals a novel esterase mutant for cosolvent-free l-menthol production. This breakthrough offers significant cost reduction and supply chain reliability for fine chemical manufacturers.
Novel patent CN118541351A details mild pyrrole synthesis avoiding chiral resolution. Delivers high purity and supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN106432199A details ultrasound resolution for ondansetron. Offers high purity and scalable manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Analysis of patent CN109438431B reveals a high-yield L-menthol route for Lamivudine. Discover cost reduction in API manufacturing and supply chain reliability.
Novel sulfonamide-based synthesis for high-purity quinolone intermediates. Safe, scalable process reducing hazardous reagents for reliable pharmaceutical supply chains.
Advanced resolution method for S-2-aminobutanamide hydrochloride improves yield and purity. Cost-effective levetiracetam intermediate manufacturing via mother liquor recycling.
Patent CN104945345B reveals a cost-effective synthesis route for chiral morpholine intermediates, offering significant supply chain stability and purity advantages for pharmaceutical manufacturing.
Novel patent CN106966912B enables efficient Dolutegravir intermediate production with high optical purity and scalable manufacturing processes for global supply chains.
Patent CN102381947B details a green 3-step synthesis for high-purity chiral 2,2'-dialkoxy-1,1'-binaphthyl, offering significant cost reduction and supply chain reliability.
Discover a novel asymmetric synthesis method for Sitagliptin base using L-DTTA. Eliminate noble metals and high-pressure hydrogenation for safer, scalable pharmaceutical manufacturing.